Recursion

Recursion is a clinical-stage biotechnology company that combines AI, automation, and massive biological datasets to industrialize drug discovery. The company has built one of the world's largest proprietary biological datasets by conducting billions of biological experiments in its automated labs, generating petabytes of cellular imaging and multi-omics data.

Recursion's AI platform, powered by its proprietary foundation model trained on biological data, identifies novel drug targets, predicts drug-disease relationships, and designs molecules with desired properties. The company's approach enables it to explore biology at a scale impossible for traditional pharmaceutical research, screening millions of potential drug candidates across thousands of disease models.

The company has multiple drug candidates in clinical trials and has signed major partnerships with pharmaceutical companies including Roche/Genentech and Bayer. Recursion's vision is to map all of biology to an AI-searchable database, fundamentally transforming how new medicines are discovered and developed.